Last reviewed · How we verify

NCT04221880

Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Thoracotomy

Completed NA Last updated 16 May 2022
What this trial tests

NA trial testing Bupivacaine Hcl 0.25% Inj in Thoracic Diseases in 60 participants. Completed in 15 March 2022.

Timeline
29 September 2021
Primary endpoint
1 March 2022
15 March 2022

Quick facts

Lead sponsorAtaturk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date29 September 2021
Primary completion1 March 2022
Estimated completion15 March 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

Adults 18 to 65, any sex, with Thoracic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thoracotomy surgery is the most painful of all surgical procedures. Inadequate postoperative pain control in these patients may cause serious morbidity related to pulmonary, cardiovascular and emotional systems. Erector Spinae Plane Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in thoracic surgery. Intravenous lidocaine exhibit analgesic activity through both the peripheral and central nervous system. Intravenous lidocaine has been shown to reduce postoperative pain intensity and accelerate postoperative recovery in many surgeries. The investigators aimed to compare the effect of lidocaine infusion and erector spinae plane block on postoperative opioid consumption and pain scores.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bupivacaine Hcl 0.25% Inj

Trials testing the same drug.

Other recruiting trials for Thoracic Diseases

Currently open trials in the same condition.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04221880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing